Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

DoubleTree by Hilton Washington DC - Crystal City

Feb 23, 2023 7:00 AM - Feb 24, 2023 4:15 PM

300 Army Navy Drive, Arlington, VA 22202

Advertising and Promotion Regulatory Affairs Conference

DIA’s Advertising and Promotion Regulatory Affairs Conference explores the current state of compliance for marketing both biopharmaceuticals and medical devices.

Power Learning Session 1: Considerations for Company Merger and Acquisition

Session Chair(s)

Heather  Banuelos, JD

Heather Banuelos, JD


King & Spalding LLP, United States

Mergers and acquisitions are commonly complex and high value activities with long-term significance. To understand and appreciate the full range of obligations, liabilities, risks and opportunities in an M&A transaction, important information relating to the commercial, financial, legal, regulatory, and administrative, the status of the assets and parties must be evaluated in a thorough and robust due diligence investigation. This session will discuss due diligence best practices for life sciences companies and provide valuable insights and strategies for cross-functional due diligence teams, with particular emphasis on the regulatory and compliance standards of the target asset or company.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Explain the purpose of due diligence
  • Describe the key steps in the due diligence process
  • Recognize the important role due diligence plays in deal negotiations, from beginning through full integration


Joshua  Oyster, JD


Joshua Oyster, JD

Ropes & Gray, United States


Nikki  Reeves, JD


Nikki Reeves, JD

King & Spalding LLP, United States


Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.